1st Quarter - Report

DRUG POLICY ALLIANCE for DRUG POLICY ALLIANCE

Firm
Client
Income
—
Expenses
$90,000
Expense method
B: tax-exempt organisations, Internal Revenue Code section 6033(b)(8)

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Opioid Overdose Reduction Act of 2014, issues related to overdose prevention. Overdose Prevention Act, issues related to overdose prevention. S. 524, Comprehensive Addiction Recovery Act Issues related to federal syringe funding ban S. 683, CARERS Act, issues related to medical marijuana. H.R. 3537, the Synthetic Drug Control Act of 2015, issues related to DEA authority.

LobbyistCovered position, as disclosed
KAITLYN BOECKER —
MICHAEL COLLINS —
BILL J PIPER —
GRANT SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 3537 (114th), S. 683 (114th), S. 524 (114th)

Law Enforcement/Crime/Criminal Justice LAW

Smarter Sentencing Act, issues relating to drug sentencing. Recidivism Reduction and Public Safety Act, issues relating to drug sentencing. Sentencing Reform and Corrections Act, issues relating to drug sentencing. FAIR Act, issues relating to civil asset forfeiture. Issues related to ending federal marijuana prohibition. Issues related to Higher Education Act drug conviction student loan ban.

LobbyistCovered position, as disclosed
LINDSAY LAWSON BATTAGLIA New —
MICHAEL COLLINS —
BILL J PIPER —
GRANT SMITH —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Budget/Appropriations BUD

Issues related to marijuana legalization, syringe funding ban, overdose prevention.

LobbyistCovered position, as disclosed
MICHAEL COLLINS —
BILL J PIPER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.